Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 902 | 359 | 749 | 1,105 | 1,153 |
| Receivables | 36 | 88 | 103 | 1,057 | 1,071 |
| Inventories | 505 | 376 | 250 | 763 | 519 |
| Other current assets | 0 | 206 | 2,620 | 171 | 137 |
| TOTAL | $1,689 | $1,029 | $3,723 | $3,097 | $2,880 |
| Non-Current Assets | |||||
| PPE Net | 476 | 929 | 1,066 | 1,252 | 1,436 |
| Intangibles | 568 | 536 | 733 | 826 | 829 |
| Other Non-Current Assets | 0 | 0 | 159 | 444 | 989 |
| TOTAL | $1,045 | $1,465 | $1,958 | $2,523 | $3,254 |
| Total Assets | $2,734 | $2,494 | $5,681 | $5,620 | $6,134 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,247 | 344 | 6,965 | 4,174 | 2,379 |
| Accounts payable and accrued liabilities | 693 | 1,186 | 437 | 603 | 626 |
| Accrued Expenses | 383 | 642 | 1,174 | 1,245 | 1,432 |
| Other current liabilities | 100 | 120 | 1,448 | N/A | N/A |
| TOTAL | $2,502 | $2,410 | $10,894 | $6,342 | $4,721 |
| Non-Current Liabilities | |||||
| Long Term Debt | 617 | 958 | 1,302 | 1,595 | 1,116 |
| Deferred Revenues | N/A | 0 | 751 | 208 | 143 |
| Other Non-Current Liabilities | 0 | 0 | -1,320 | -2,385 | -2,319 |
| TOTAL | $979 | $1,713 | $3,196 | $3,416 | $2,980 |
| Total Liabilities | $3,481 | $4,123 | $14,090 | $9,758 | $7,701 |
| Shareholders' Equity | |||||
| Common Shares | 27,966 | 24,402 | 23,686 | 23,133 | 22,156 |
| Retained earnings | -37,136 | -34,415 | -42,134 | -37,100 | -33,210 |
| Other shareholders' equity | 15 | 66 | 141 | 0 | 1,662 |
| TOTAL | $-747 | $-1,629 | $-10,558 | $-6,523 | $-3,886 |
| Total Liabilities And Equity | $2,734 | $2,494 | $3,532 | $3,235 | $3,815 |